MUMBAI, March 11 - India's NSE index provisionally fell, retreating from a record high hit earlier in the day, as investors booked profits in some recent outperformers such as Reliance Industries ahead of key inflation data.
* Shares in Reliance Infrastructure Ltd gain 5 percent, while Tata Power surges 4.1 percent, after Delhi's electricity regulator laid out a plan to pay the utilities for some of the money owed to them by consumers in the Indian capital. * The Delhi Electricity Regulatory Commission will allow units of both companies to recover 80 billion rupees ($1.31 billion) over the next eight years, DERC's Chairman PD Sudhakar told Reuters. * Domestic electricity utilities have long suffered financially as I
* India's broader NSE index falls 0.4 percent, retreating further after hitting a record high at 6,562.85 earlier in the day, which had marked its third consecutive all-time high. * A fall, if sustained, would snap a five-day winning run in which the index gained 5 percent. * Profit-taking hits some of the recent outperformers: Reliance Industries Ltd is down 0.56 percent after surging 9.7 percent over the previous three sessions, while HDFC Bank Ltd loses 1.25 percent after jumping 9.8 percent
* Shares in Sesa Sterlite Ltd fell as much as 3.24 percent, adding to their 1.2 percent fall in the previous session, as iron ore prices posted their biggest one-day drop in over four years on Monday. * Sesa is India's largest private sector iron ore exporter. * Sesa shares are down 11.3 percent so far this year, widely under-performing the NSE's 3.6 percent gain. (email@example.com/indulal.p.thomsonreuters.com@reut ers.net)
MUMBAI, March 11 - India's NSE index rose 0.3 percent to a third consecutive record high as lenders such as ICICI Bank extended a powerful rally on the back of signs of an improving domestic economy and hopes that easing inflation will keep interest rates steady.
* Nifty futures traded on the Singapore Exchange are down 0.09 percent, while the MSCI-Asia Pacific excluding Japan index gains 0.31 percent. * Asian markets were finding their feet on Tuesday after a rocky ride the previous session, though uncertainty about the true state of China's economy kept the mood brittle and commodity prices depressed. * U.S. stocks dipped on Monday, weighed down by soft data out of China and Boeing's latest production setback. KEY EVENTS/FACTORS TO WATCH Supreme co
* BSE index gains 0.07 pct; NSE ends 0.16 pct higher * Reliance Industries up on KG-D6 discovery hopes * Metal stocks plunge on worries of China slowdown By Abhishek Vishnoi MUMBAI, March 10 - India's BSE index ended up slightly on Monday after rising to a record high for a third consecutive session as strong foreign buying continued to boost domestic-focused shares such as those of HDFC Bank, but momentum waned as exporters slumped on a stronger currency. Sentimen
MUMBAI, Mar 10 - India's BSE index managed slight gains on Monday after earlier posting its third consecutive record high as shares of domestic-focused companies, including HDFC Bank, extended a rally on the back of signs of strong foreign buying.
* Shares of Indian metal companies plunged after data on Saturday showed China's exports unexpectedly tumbled in February, raising fears of a slowdown in the world's second-largest economy. * India's BSE metals index is down 7.2 percent year-to-date, while the benchmark BSE index is up 3.4 percent in the same period. * "Metal stocks have not yet participated in the ongoing rally on fears relating to the slowdown in China," said Varun Khandelwal, fund manager, Bullero Capital Pvt Ltd. "The rece
* Shares in India's Sun Pharmaceutical Industries Ltd fall as much as 2.8 percent after the U.S. Food and Drug Administration said the drug maker was voluntarily recalling 2,528 bottles of its generic version of diabetes drug Glumetza from U.S.-based Santarus Inc. * Sun began recalling the bottles of metformin HCL extended-release tables in the United States on Jan. 28, 2014, after it received a customer complaint that one of the bottles contained tablets of epilepsy drug Gabapentin, the FDA sa
Nifty Most Actives
NEW DELHI - Consumer inflation and industrial output data on Wednesday will likely offer little evidence of a respite from high inflation and weak economic growth before a general election that begins next month.